|
Reserpine, Hydralazine Hcl And HydrochlorothiazideDrug - Reserpine, Hydralazine Hcl And Hydrochlorothiazide The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Hydralazine Hydrochloride; Hydrochlorothiazide; Reserpine
Strength -
25MG;15MG;0.1MG
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
085549
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Watson Laboratories Inc
Reserpine, Hydralazine Hcl And Hydrochlorothiazide
Hydralazine Hcl-hydrochlorothiazide-reserpine 25mg;15mg;0.1mg Tablet; Oral
Hydralazine, Hydrochlorothiazide W/ Reserpine 25mg;15mg;0.1mg Tablet; Oral Hydrap-es 25mg;15mg;0.1mg Tablet; Oral Hydrochlorothiazide W/ Reserpine And Hydralazine 25mg;15mg;0.1mg Tablet; Oral Hydroserpine Plus (r-h-h) 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Reserpine, Hydralazine Hcl And Hydrochlorothiazide 25mg;15mg;0.1mg Tablet; Oral Cam-ap-es 25mg;15mg;0.1mg Tablet; Oral Hydralazine Hcl, Hydrochlorothiazide And Reserpine 25mg;15mg;0.1mg Tablet; Oral NewDrugInformation |